PAR paradigm biopharmaceuticals limited..

iPPS and Inflammation, page-3

  1. 1,224 Posts.
    lightbulb Created with Sketch. 234
    I just spoke with a good friend of mine who told me his father is in Argentina and just been diagnosed with Alzheimers. I am pretty sure they have gone over to get ‘cheap’ specialist care or treatment that isn’t available in Aus.

    Neuroinflammation, or inflammation in the brain, has emerged as an important line of inquiry in Alzheimer's disease research. Markers of inflammation, such as certain immune molecules called cytokines, are boosted in Alzheimer's disease mouse models and in the brains of people with Alzheimer's disease.

    I do recall an earlier post probably from Moz about the ability for the molecule to cross the blood brain barrier.

    His parents are pretty open to suggestions for treatment and I suggested to try Pentosan. If they proceed I will get updates
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
41.5¢
Change
-0.015(3.49%)
Mkt cap ! $164.9M
Open High Low Value Volume
43.5¢ 44.0¢ 41.5¢ $216.2K 510.9K

Buyers (Bids)

No. Vol. Price($)
1 12344 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 2286 1
View Market Depth
Last trade - 16.10pm 11/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.